Ask Our Experts

FDA approves first blood test to detect colorectal cancer

FDA approves first blood test to detect colorectal cancer

On July 29, the U.S. Food and Drug Administration (FDA) approved Guardant Health’s Shield™ test, the first colorectal cancer screening test that analyzes a blood sample to identify molecular signs of cancer. The latest research shows that early detection of cancer improves treatment outcomes and survival rates and experts predict that having a non-invasive option will help to screen more patients and catch colorectal cancer at treatable stages.
Read More

Published Research

The Importance of Clinical Trials in Cancer Care

The Importance of Clinical Trials in Cancer Care

Clinical trials are pivotal in advancing cancer treatment and improving patient outcomes. They offer patients access to cutting-edge treatments while contributing valuable insights that drive the evolution of cancer care. This whitepaper examines clinical trials as a potential value lever within employer-sponsored health plans, highlighting their dual impact on enhancing cancer care and managing healthcare costs.
Read More

Subscribe to our Newsletter


A doctor takes a patient's blood pressure.

Contact

Want to speak with a
representative?

Connect

Follow us
on LinkedIn